NL-OMON51846已完成不适用
Bioequivalence of a diabetes specific tube feed with a new carbohydrate source - EquiDia
utricia Research0 个研究点目标入组 22 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
入选标准
- •1. Age >= 18 and <= 65 years
- •2. Body Mass Index (BMI) >= 18.5 and <= 27.0 kg/m2
- •3. Written informed consent
- •4. Willingness and ability to comply with the protocol
- •5. Judged by the Investigator to be in good health
排除标准
- •1. Known Diabetes Mellitus type I or type II, rebound hypoglycaemia and/or any
- •other medical condition that
- •2. Any use of anticoagulants, systemic steroids, protease inhibitors or
- •antipsychotics and/or any medication known to affect glucose tolerance and/or
- •to influence digestion and absorption of nutrients within 1 week of screening,
- •in opinion of the Investigator
- •3. Any known disease which influences digestion and absorption of nutrients
- •within 1 week of screening (in the opinion of the Investigator)
- •4. Allergy to soy and/or any other known relevant food allergy or intolerance
- •in opinion of the Investigator
- •5. Adherence to a strict vegan diet
- •6. Adherence to a weight loss program
- •7. Picky/fussy eater (being very selective about what to eat) or eating disorder
- •8. Known pregnancy and/or lactation
- •9. Current smoking or stopped smoking for < 1 month prior to screening (except
- •for incidental smoking of <= 3 cigarettes/cigars/pipes per week on average in
- •the last month)
- •10. Average alcohol use of > 21 glasses per week for men or > 14 glasses per
- •week for women (on average during the last 6 months)
- •11. Drug or medicine abuse in opinion of the Investigator
- •12. Any known bleeding disorder
- •13. Active participation in any other clinical study with investigational or
- •marketed products concomitantly or within 4 weeks before study visit 1, in the
- •opinion of the Investigator
- •14. Major medical or surgical event requiring hospitalization within the
- •preceding 3 months and/or scheduled in the period of study participation
- •relevant in the opinion of the Investigator
- •15. Investigator*s uncertainty about the willingness or ability of the subject
- •to comply with the protocol requirements
- •16. Employees of Nutricia Research and/or family members or relatives of
研究者
相似试验
已完成
不适用
Bioequivalence of a Diabetes Specific Tube FeedPostprandial Glucose ResponseNCT05453838Nutricia Research22
已完成
2 期
Comparison of Enteral Products for Tube Fed Patients With Type 2 DiabetesType 2 Diabetes MellitusNCT00544206Abbott Nutrition11
终止
不适用
Efficacy and Safety Study of a Low-carbohydrate Tube Feed in Critically Ill Patients Under Insulin TherapyAneurysmal Subarachnoid HemorrhageNCT02503527Fresenius Kabi28
已完成
2 期
Comparison of Nutritional Products for People With Type 2 DiabetesType 2 Diabetes MellitusNCT00520065Abbott Nutrition33
尚未招募
不适用
Evaluation of hybrid ex vivo expanded diabetic peripheral blood endothelial progenitor cell functioDiabetes MellitusJPRN-UMIN000006352Juntendo University School of Medicie Department of Plastic Surgery40